Ascend Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,622	Closed	-$2.64M	–	204
2018 Q1	$2.64M	Buy	+25,622	New	+$2.64M	0.11%	152